BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 30207489)

  • 1. The Italian Mastocytosis Registry: 6-year experience from a hospital-based registry.
    Merante S; Ferretti VV; Elena C; Brazzelli V; Zanotti R; Neri I; Magliacane D; Belloni Fortina A; Ingeborg F; Pastorello EA; Pieri L; Papayannidis C; Mauro M; Grifoni F; Minelli R; Guggiari E; Difonzo E; Bocchia M; Caroppo F; Di Nuzzo S; Elli EM; Rondoni M; Ciccocioppo R; Di Stefano M; Bossi G; Boveri E; Bonadonna P; Giona F; Valent P; Triggiani M
    Future Oncol; 2018 Nov; 14(26):2713-2723. PubMed ID: 30207489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical observations in cutan mastocytosis].
    Mihalik N; Hidvégi B; Hársing J; Várkonyi J; Csomor J; Kovalszky I; Marschalkó M; Kárpáti S
    Orv Hetil; 2013 Sep; 154(37):1469-75. PubMed ID: 24016753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of KIT D816V in peripheral blood of children with manifestations of cutaneous mastocytosis suggests systemic disease.
    Carter MC; Bai Y; Ruiz-Esteves KN; Scott LM; Cantave D; Bolan H; Eisch R; Sun X; Hahn J; Maric I; Metcalfe DD
    Br J Haematol; 2018 Dec; 183(5):775-782. PubMed ID: 30488427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.
    Álvarez-Twose I; Jara-Acevedo M; Morgado JM; García-Montero A; Sánchez-Muñoz L; Teodósio C; Matito A; Mayado A; Caldas C; Mollejo M; Orfao A; Escribano L
    J Allergy Clin Immunol; 2016 Jan; 137(1):168-178.e1. PubMed ID: 26100086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mastocytosis and related disorders.
    Chiu A; Orazi A
    Semin Diagn Pathol; 2012 Feb; 29(1):19-30. PubMed ID: 22372203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mastocytosis: state of the art.
    Horny HP; Sotlar K; Valent P
    Pathobiology; 2007; 74(2):121-32. PubMed ID: 17587883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult-onset mastocytosis in the skin is highly suggestive of systemic mastocytosis.
    Berezowska S; Flaig MJ; Ruëff F; Walz C; Haferlach T; Krokowski M; Kerler R; Petat-Dutter K; Horny HP; Sotlar K
    Mod Pathol; 2014 Jan; 27(1):19-29. PubMed ID: 23807778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical aspects of paediatric mastocytosis: a review of 101 cases.
    Lange M; Niedoszytko M; Renke J; Gleń J; Nedoszytko B
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):97-102. PubMed ID: 22126331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kit Mutations: New Insights and Diagnostic Value.
    Falchi L; Verstovsek S
    Immunol Allergy Clin North Am; 2018 Aug; 38(3):411-428. PubMed ID: 30007460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Approach to Paediatric Mastocytosis: Implications of KIT D816V Mutation Detection in Peripheral Blood.
    Czarny J; Żuk M; Zawrocki A; Plata-Nazar K; Biernat W; Niedoszytko M; Ługowska-Umer H; Nedoszytko B; Wasąg B; Nowicki RJ; Lange M
    Acta Derm Venereol; 2020 May; 100(10):adv00149. PubMed ID: 32399575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Impact of Skin Lesions in Mastocytosis: A Multicenter Study of the European Competence Network on Mastocytosis.
    Aberer E; Sperr WR; Bretterklieber A; Avian A; Hadzijusufovic E; Kluin-Nelemans HC; Oude Elberink H; van Anrooij B; Niedoszytko M; Lange M; Górska A; Elena C; Brazzelli V; Belloni Fortina A; Caroppo F; Hartmann K; Illerhaus A; Reiter A; Jawhar M; Bonadonna P; Zanotti R; Triggiani M; Parente R; Gotlib J; Doubek M; von Bubnoff N; Fuchs D; Sabato V; Brockow K; Jäkel N; Panse J; Valent P
    J Invest Dermatol; 2021 Jul; 141(7):1719-1727. PubMed ID: 33581142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Systemic mastocytosis].
    Niedoszytko M; Lange M; Chelminska M; Jaśkiewicz K; Piskosz A; Wasag B; Lewandowski K; Mital A; Renke J; Gruchała-Niedoszytko M; Woźniak M; Babińska A; Jassem E
    Pneumonol Alergol Pol; 2005; 73(3):239-44. PubMed ID: 16989160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mastocytosis: a comprehensive insight.
    VAN Gysel D; DE Maeseneer H; Oranje AP
    G Ital Dermatol Venereol; 2016 Aug; 151(4):385-96. PubMed ID: 27070304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tryptase detection in bone-marrow blood: a new diagnostic tool in systemic mastocytosis.
    Proelss J; Wenzel J; Ko Y; Bieber T; Bauer R
    J Am Acad Dermatol; 2007 Mar; 56(3):453-7. PubMed ID: 17317486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of urticaria pigmentosa into indolent systemic mastocytosis: abnormal immunophenotype of mast cells without evidence of c-kit mutation ASP-816-VAL.
    Noack F; Escribano L; Sotlar K; Nunez R; Schuetze K; Valent P; Horny HP
    Leuk Lymphoma; 2003 Feb; 44(2):313-9. PubMed ID: 12688351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency of isolated cutaneous involvement in adult mastocytosis: a cohort study.
    Fradet M; Negretto M; Tournier E; Laurent C; Apoil PA; Evrard S; Degboe Y; Del Mas V; Lamant L; Dubreuil P; Laroche M; Mailhol C; Hermine O; Paul C; Bulai Livideanu C
    J Eur Acad Dermatol Venereol; 2019 Sep; 33(9):1713-1718. PubMed ID: 31009132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum tryptase correlates with the KIT D816V mutation burden in adults with indolent systemic mastocytosis.
    Kristensen T; Broesby-Olsen S; Vestergaard H; Bindslev-Jensen C; Møller MB;
    Eur J Haematol; 2013 Aug; 91(2):106-11. PubMed ID: 23621866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of clinical findings, tryptase levels, and bone marrow histopathology in the management of pediatric mastocytosis.
    Carter MC; Clayton ST; Komarow HD; Brittain EH; Scott LM; Cantave D; Gaskins DM; Maric I; Metcalfe DD
    J Allergy Clin Immunol; 2015 Dec; 136(6):1673-1679.e3. PubMed ID: 26044856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the aberrant expression of CD2 and CD25 by skin mast cells truly correlate with systemic involvement in patients presenting with mastocytosis in the skin?
    Lange M; Żawrocki A; Nedoszytko B; Wasąg B; Niedoszytko M; Jassem E; Nowicki R; Żmijewski MA; Biernat W
    Int Arch Allergy Immunol; 2014; 165(2):104-10. PubMed ID: 25402852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scoring the Risk of Having Systemic Mastocytosis in Adult Patients with Mastocytosis in the Skin.
    Fuchs D; Kilbertus A; Kofler K; von Bubnoff N; Shoumariyeh K; Zanotti R; Bonadonna P; Scaffidi L; Doubek M; Elberink HO; Span LFR; Hermine O; Elena C; Benvenuti P; Yavuz AS; Brockow K; Zink A; Aberer E; Gorska A; Romantowski J; Hadzijusufovic E; Fortina AB; Caroppo F; Perkins C; Illerhaus A; Panse J; Vucinic V; Jawhar M; Sabato V; Triggiani M; Parente R; Bergström A; Breynaert C; Gotlib J; Reiter A; Hartmann K; Niedoszytko M; Arock M; Kluin-Nelemans HC; Sperr WR; Greul R; Valent P
    J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1705-1712.e4. PubMed ID: 33346151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.